$559 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 128 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 58.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | SPDR SERIES TRUSTput | $43,509,000 | -23.9% | 5,566 | -30.4% | 7.39% | -33.8% | |
| CELG | CELGENE CORP | $32,468,000 | +4.4% | 250,000 | 0.0% | 5.52% | -9.3% | |
| BIIB | Buy | BIOGEN INC | $24,422,000 | +19.1% | 90,000 | +20.0% | 4.15% | +3.5% |
| MRK | Buy | MERCK & CO INC | $20,509,000 | +9.4% | 320,000 | +8.5% | 3.48% | -4.9% |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $19,404,000 | – | 450,000 | +100.0% | 3.30% | – |
| New | POWERSHARES QQQ TRUSTput | $17,188,000 | – | 1,200 | +100.0% | 2.92% | – | |
| GILD | New | GILEAD SCIENCES INC | $16,279,000 | – | 230,000 | +100.0% | 2.77% | – |
| NVS | Sell | NOVARTIS A Gsponsored adr | $15,960,000 | -15.8% | 200,000 | -21.6% | 2.71% | -26.8% |
| New | BIOGEN INCcall | $14,480,000 | – | 500 | +100.0% | 2.46% | – | |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $13,819,000 | +69.4% | 248,000 | +65.3% | 2.35% | +47.2% |
| PFE | PFIZER INC | $13,100,000 | -1.8% | 390,000 | 0.0% | 2.23% | -14.6% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $12,913,000 | -9.7% | 383,047 | -20.7% | 2.19% | -21.5% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $12,167,000 | – | 100,000 | +100.0% | 2.07% | – |
| SHPG | Sell | SHIRE PLCsponsored adr | $11,321,000 | -26.6% | 68,500 | -68.1% | 1.92% | -36.2% |
| ITRN | Buy | ITURAN LOCATION AND CONTROL | $9,528,000 | +9.8% | 304,421 | +8.2% | 1.62% | -4.6% |
| CLVS | New | CLOVIS ONCOLOGY INC | $8,708,000 | – | 93,000 | +100.0% | 1.48% | – |
| Buy | TEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0 | $8,641,000 | +127.4% | 14,535 | +120.7% | 1.47% | +97.6% | |
| TSRO | New | TESARO INC | $7,692,000 | – | 55,000 | +100.0% | 1.31% | – |
| ORBK | Buy | ORBOTECH LTDord | $6,972,000 | +37.6% | 213,740 | +36.1% | 1.18% | +19.7% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $6,812,000 | – | 75,000 | +100.0% | 1.16% | – |
| Sell | CELGENE CORPcall | $6,771,000 | -54.5% | 500 | -58.3% | 1.15% | -60.5% | |
| NICE | Buy | NICE LTDsponsored adr | $6,695,000 | +55.0% | 85,052 | +33.9% | 1.14% | +34.7% |
| VSAR | Buy | VERSARTIS INC | $6,588,000 | +2.9% | 377,524 | +25.8% | 1.12% | -10.6% |
| ARRY | ARRAY BIOPHARMA INC | $5,859,000 | -6.4% | 700,000 | 0.0% | 1.00% | -18.6% | |
| New | MYLAN N Vcall | $5,849,000 | – | 1,500 | +100.0% | 0.99% | – | |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $5,566,000 | +114.1% | 1,100,000 | +10.0% | 0.95% | +86.2% |
| FGEN | FIBROGEN INC | $5,352,000 | +31.0% | 165,700 | 0.0% | 0.91% | +13.8% | |
| CLLS | Buy | CELLECTIS S Asponsored ads | $5,261,000 | +37.3% | 203,764 | +27.6% | 0.89% | +19.4% |
| V | VISA INC | $4,966,000 | +5.5% | 52,951 | 0.0% | 0.84% | -8.3% | |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $4,884,000 | +185.4% | 2,200,000 | -24.1% | 0.83% | +148.5% |
| IMMU | Sell | IMMUNOMEDICS INC | $4,857,000 | -21.0% | 550,000 | -42.1% | 0.82% | -31.4% |
| FB | Buy | FACEBOOK INCcl a | $4,857,000 | +89.0% | 32,167 | +77.8% | 0.82% | +64.3% |
| UNP | Buy | UNION PAC CORP | $4,618,000 | +52.1% | 42,400 | +47.9% | 0.78% | +32.2% |
| SELB | SELECTA BIOSCIENCES INC | $4,539,000 | +38.7% | 228,534 | 0.0% | 0.77% | +20.5% | |
| CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $4,501,000 | +15.0% | 13,362 | +11.7% | 0.76% | 0.0% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $4,486,000 | -37.3% | 161,617 | -36.7% | 0.76% | -45.5% |
| CSTE | Buy | CAESARSTONE LTD | $4,304,000 | +31.9% | 122,797 | +36.5% | 0.73% | +14.6% |
| NERV | New | MINERVA NEUROSCIENCES INC | $4,193,000 | – | 473,769 | +100.0% | 0.71% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $4,139,000 | +81.4% | 296,310 | +78.2% | 0.70% | +57.6% |
| RXDX | New | IGNYTA INC | $4,140,000 | – | 400,000 | +100.0% | 0.70% | – |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $4,117,000 | +23.2% | 875,931 | +31.0% | 0.70% | +6.9% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $4,103,000 | – | 150,000 | +100.0% | 0.70% | – |
| RTRX | RETROPHIN INC | $4,055,000 | +5.0% | 209,131 | 0.0% | 0.69% | -8.7% | |
| GOOGL | ALPHABET INCcap stk cl a | $4,040,000 | +9.6% | 4,346 | 0.0% | 0.69% | -4.7% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $4,028,000 | +13.0% | 400,000 | -20.0% | 0.68% | -1.9% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $3,988,000 | – | 50,000 | +100.0% | 0.68% | – |
| NOMD | New | NOMAD FOODS LTD | $3,782,000 | – | 268,072 | +100.0% | 0.64% | – |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $3,721,000 | +13.3% | 125,000 | +13.6% | 0.63% | -1.6% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $3,632,000 | +114.0% | 30,000 | +100.0% | 0.62% | +85.8% |
| New | TEVA PHARMACEUTICAL INDS LTDput | $3,603,000 | – | 1,120 | +100.0% | 0.61% | – | |
| GLYC | Sell | GLYCOMIMETICS INC | $3,580,000 | -15.0% | 320,796 | -58.6% | 0.61% | -26.2% |
| ADMS | ADAMAS PHARMACEUTICALS INC | $3,419,000 | -0.1% | 195,500 | 0.0% | 0.58% | -13.2% | |
| SEDG | Buy | SOLAREDGE TECHNOLOGIES INC | $3,420,000 | +369.1% | 171,018 | +265.8% | 0.58% | +306.3% |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $3,220,000 | +1.4% | 90,167 | 0.0% | 0.55% | -11.9% | |
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $3,118,000 | -46.2% | 257,665 | -7.7% | 0.53% | -53.2% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $3,100,000 | +19.6% | 200,000 | +33.3% | 0.53% | +3.9% |
| SVRA | New | SAVARA INC | $3,095,000 | – | 526,315 | +100.0% | 0.53% | – |
| TXMD | THERAPEUTICSMD INC | $3,057,000 | -26.8% | 580,000 | 0.0% | 0.52% | -36.4% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $3,044,000 | -31.0% | 385,301 | 0.0% | 0.52% | -40.1% | |
| OVID | New | OVID THERAPEUTICS INC | $3,042,000 | – | 305,674 | +100.0% | 0.52% | – |
| BLCM | Buy | BELLICUM PHARMACEUTICALS INC | $2,920,000 | +18.3% | 250,000 | +25.0% | 0.50% | +2.9% |
| BOLD | New | AUDENTES THERAPEUTICS INC | $2,870,000 | – | 150,000 | +100.0% | 0.49% | – |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,852,000 | -56.1% | 62,000 | -58.7% | 0.48% | -61.8% |
| Buy | ADVANCE AUTO PARTS INCcall | $2,800,000 | -1.5% | 250 | +25.0% | 0.48% | -14.4% | |
| STML | STEMLINE THERAPEUTICS INC | $2,760,000 | +7.6% | 300,000 | 0.0% | 0.47% | -6.4% | |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $2,759,000 | – | 833,633 | +100.0% | 0.47% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $2,756,000 | +76.2% | 501,000 | +24.9% | 0.47% | +52.9% |
| CLSD | CLEARSIDE BIOMEDICAL INC | $2,733,000 | +14.7% | 300,000 | 0.0% | 0.46% | -0.4% | |
| ENDP | New | ENDO INTL PLC | $2,681,000 | – | 240,000 | +100.0% | 0.46% | – |
| CYTK | Buy | CYTOKINETICS INC | $2,638,000 | +34.9% | 217,990 | +43.2% | 0.45% | +17.3% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $2,558,000 | -35.0% | 490,000 | -24.2% | 0.44% | -43.4% |
| CASC | Buy | CASCADIAN THERAPEUTICS INC | $2,531,000 | +5.2% | 681,210 | +17.2% | 0.43% | -8.5% |
| SNA | SNAP ON INC | $2,496,000 | -6.3% | 15,797 | 0.0% | 0.42% | -18.6% | |
| LRCX | New | LAM RESEARCH CORP | $2,385,000 | – | 16,860 | +100.0% | 0.40% | – |
| SBPH | New | SPRING BK PHARMACEUTICALS IN | $2,370,000 | – | 175,000 | +100.0% | 0.40% | – |
| ORCL | New | ORACLE CORP | $2,369,000 | – | 47,250 | +100.0% | 0.40% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $2,247,000 | – | 40,000 | +100.0% | 0.38% | – |
| New | NEURODERM LTD | $2,228,000 | – | 74,500 | +100.0% | 0.38% | – | |
| PRTA | New | PROTHENA CORP PLC | $2,165,000 | – | 40,000 | +100.0% | 0.37% | – |
| ALBO | New | ALBIREO PHARMA INC | $2,133,000 | – | 103,526 | +100.0% | 0.36% | – |
| DOVA | New | DOVA PHARMACEUTICALS INC | $2,118,000 | – | 95,000 | +100.0% | 0.36% | – |
| New | O REILLY AUTOMOTIVE INC NEWcall | $2,043,000 | – | 100 | +100.0% | 0.35% | – | |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $2,039,000 | +92.0% | 11,688 | +69.1% | 0.35% | +66.3% |
| OBSV | Buy | OBSEVA SA | $1,979,000 | -9.9% | 231,497 | +9.7% | 0.34% | -21.7% |
| SGEN | SEATTLE GENETICS INC | $1,863,000 | -17.7% | 36,000 | 0.0% | 0.32% | -28.3% | |
| MRNS | MARINUS PHARMACEUTICALS INC | $1,824,000 | -22.6% | 1,331,421 | 0.0% | 0.31% | -32.8% | |
| TJX | Buy | TJX COS INC NEW | $1,783,000 | -0.7% | 24,700 | +8.8% | 0.30% | -13.7% |
| ARDX | ARDELYX INC | $1,760,000 | -59.7% | 345,000 | 0.0% | 0.30% | -64.9% | |
| PRQR | PROQR THRAPEUTICS N V | $1,716,000 | +4.0% | 330,000 | 0.0% | 0.29% | -9.6% | |
| SPNS | SAPIENS INTL CORP N V | $1,648,000 | -13.1% | 147,306 | 0.0% | 0.28% | -24.5% | |
| AKAOQ | Sell | ACHAOGEN INC | $1,630,000 | -67.7% | 75,000 | -62.5% | 0.28% | -71.9% |
| TSEM | TOWER SEMICONDUCTOR LTD | $1,602,000 | +3.5% | 67,155 | 0.0% | 0.27% | -10.2% | |
| SMMT | Sell | SUMMIT THERAPEUTICS PLCspons ads | $1,561,000 | -20.6% | 142,018 | -3.7% | 0.26% | -31.2% |
| FLEX | New | FLEX LTDord | $1,541,000 | – | 94,500 | +100.0% | 0.26% | – |
| EDGE | EDGE THERAPEUTICS INC | $1,539,000 | +12.6% | 150,000 | 0.0% | 0.26% | -2.2% | |
| WAB | New | WABTEC CORP | $1,519,000 | – | 16,600 | +100.0% | 0.26% | – |
| VTVT | VTV THERAPEUTICS INCcl a | $1,491,000 | -24.1% | 300,000 | 0.0% | 0.25% | -34.1% | |
| MGNX | MACROGENICS INC | $1,422,000 | -5.8% | 81,200 | 0.0% | 0.24% | -18.0% | |
| ISHARES TRcall | $1,415,000 | +1.7% | 100 | 0.0% | 0.24% | -11.8% | ||
| MA | MASTERCARD INCORPORATEDcl a | $1,400,000 | +8.0% | 11,525 | 0.0% | 0.24% | -5.9% | |
| ALRN | New | AILERON THERAPEUTICS INC | $1,394,000 | – | 125,000 | +100.0% | 0.24% | – |
| EVOK | EVOKE PHARMA INC | $1,280,000 | -17.4% | 500,000 | 0.0% | 0.22% | -28.4% | |
| KRNT | Buy | KORNIT DIGITAL LTD | $1,109,000 | +6423.5% | 57,300 | +6266.7% | 0.19% | +6166.7% |
| XLRN | Sell | ACCELERON PHARMA INC | $1,064,000 | -59.8% | 35,000 | -65.0% | 0.18% | -65.0% |
| VTGN | VISTAGEN THERAPEUTICS INC | $1,017,000 | -4.6% | 544,100 | 0.0% | 0.17% | -16.8% | |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $874,000 | – | 62,085 | +100.0% | 0.15% | – |
| VRSK | New | VERISK ANALYTICS INC | $793,000 | – | 9,400 | +100.0% | 0.14% | – |
| ITEK | INOTEK PHARMACEUTICALS CORP | $763,000 | -5.1% | 401,764 | 0.0% | 0.13% | -17.2% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $718,000 | -45.3% | 228,029 | -30.5% | 0.12% | -52.3% |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $522,000 | +1.8% | 193,212 | +54.6% | 0.09% | -11.0% |
| CAMT | New | CAMTEK LTDord | $478,000 | – | 99,035 | +100.0% | 0.08% | – |
| CATB | Sell | CATABASIS PHARMACEUTICALS IN | $409,000 | -34.1% | 288,030 | -25.8% | 0.07% | -43.0% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $398,000 | -88.8% | 5,000 | -90.0% | 0.07% | -90.2% |
| UNH | UNITEDHEALTH GROUP INC | $371,000 | +13.1% | 2,000 | 0.0% | 0.06% | -1.6% | |
| WSO | New | WATSCO INC | $324,000 | – | 2,100 | +100.0% | 0.06% | – |
| NVMI | New | NOVA MEASURING INSTRUMENTS L | $306,000 | – | 13,844 | +100.0% | 0.05% | – |
| MHK | MOHAWK INDS INC | $266,000 | +5.6% | 1,100 | 0.0% | 0.04% | -8.2% | |
| SEE | SEALED AIR CORP NEW | $201,000 | +2.6% | 4,500 | 0.0% | 0.03% | -10.5% | |
| PTN | Sell | PALATIN TECHNOLOGIES INC | $203,000 | -78.7% | 470,983 | -83.8% | 0.03% | -81.7% |
| LOW | LOWES COS INC | $202,000 | -5.6% | 2,600 | 0.0% | 0.03% | -19.0% | |
| SERV | SERVICEMASTER GLOBAL HLDGS I | $196,000 | -6.2% | 5,000 | 0.0% | 0.03% | -19.5% | |
| ULTI | ULTIMATE SOFTWARE GROUP INC | $168,000 | +7.7% | 800 | 0.0% | 0.03% | -3.3% | |
| CMG | CHIPOTLE MEXICAN GRILL INC | $166,000 | -6.7% | 400 | 0.0% | 0.03% | -20.0% | |
| XRAY | New | DENTSPLY SIRONA INC | $162,000 | – | 2,500 | +100.0% | 0.03% | – |
| LVNTA | New | LIBERTY INTERACTIVE CORP | $157,000 | – | 3,000 | +100.0% | 0.03% | – |
| TRIP | TRIPADVISOR INC | $153,000 | -11.6% | 4,000 | 0.0% | 0.03% | -23.5% | |
| VSTO | New | VISTA OUTDOOR INC | $135,000 | – | 6,000 | +100.0% | 0.02% | – |
| ECL | New | ECOLAB INC | $133,000 | – | 1,000 | +100.0% | 0.02% | – |
| ATHX | Exit | ATHERSYS INC | $0 | – | -773 | -100.0% | 0.00% | – |
| TRVN | Exit | TREVENA INC | $0 | – | -116,800 | -100.0% | -0.08% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -25,500 | -100.0% | -0.14% | – |
| GNMX | Exit | AEVI GENOMIC MEDICINE INC | $0 | – | -405,000 | -100.0% | -0.15% | – |
| RPRX | Exit | REPROS THERAPEUTICS INC | $0 | – | -778,800 | -100.0% | -0.18% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -100,000 | -100.0% | -0.21% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -242,000 | -100.0% | -0.23% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -0.25% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -40,000 | -100.0% | -0.28% | – |
| AAP | Exit | ADVANCE AUTO PARTS INC | $0 | – | -11,237 | -100.0% | -0.33% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.39% | – |
| TBT | Exit | PROSHARES TR | $0 | – | -55,950 | -100.0% | -0.43% | – |
| FWP | Exit | FORWARD PHARMA A/Ssponsored adr | $0 | – | -108,023 | -100.0% | -0.46% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -140,000 | -100.0% | -0.53% | – |
| SBUX | Exit | STARBUCKS CORP | $0 | – | -46,631 | -100.0% | -0.53% | – |
| SLB | Exit | SCHLUMBERGER LTD | $0 | – | -34,911 | -100.0% | -0.53% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -35,000 | -100.0% | -0.54% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -45,000 | -100.0% | -0.67% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.73% | – |
| Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -1,500 | -100.0% | -0.93% | – | |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $0 | – | -172,000 | -100.0% | -1.08% | – |
| Exit | ISHARES TRput | $0 | – | -500 | -100.0% | -1.36% | – | |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -480,000 | -100.0% | -1.39% | – |
| Exit | NEUROCRINE BIOSCIENCES INCput | $0 | – | -1,500 | -100.0% | -1.57% | – | |
| Exit | SPDR S&P 500 ETF TRput | $0 | – | -1,000 | -100.0% | -4.65% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.